{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:25:20Z","timestamp":1792790720634,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Intramural competitive research grant from CIBERNED"],"award-info":[{"award-number":["Intramural competitive research grant from CIBERNED"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Intramural competitive research grant from CIBERNED"],"award-info":[{"award-number":["Intramural competitive research grant from CIBERNED"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Intramural competitive research grant from CIBERNED"],"award-info":[{"award-number":["Intramural competitive research grant from CIBERNED"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PID2021-126848NB-I00"],"award-info":[{"award-number":["PID2021-126848NB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PID2023-150743OB-I00"],"award-info":[{"award-number":["PID2023-150743OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Galician Government","award":["ED431C 2022\/41"],"award-info":[{"award-number":["ED431C 2022\/41"]}],"id":[{"id":"https:\/\/ror.org\/05n3rrk65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Regional European Development Fund","award":["FEDER"],"award-info":[{"award-number":["FEDER"]}]},{"name":"Regional European Development Fund","award":["FEDER"],"award-info":[{"award-number":["FEDER"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01230-6","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T03:57:01Z","timestamp":1765339021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson\u2019s disease patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Laura","family":"Camacho-Me\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen M.","family":"Labandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana B.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateo V.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Bejr-Kasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Molina-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Atienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Lanciego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8243-9791","authenticated-orcid":false,"given":"Jose Luis","family":"Labandeira-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1354-8799","authenticated-orcid":false,"given":"Ana I.","family":"Rodriguez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"1230_CR1","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s13311-018-0646-z","volume":"15","author":"AI Rodriguez-Perez","year":"2018","unstructured":"Rodriguez-Perez, A. I. et al. Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death. Neurotherapeutics 15, 1063\u20131081 (2018).","journal-title":"Neurotherapeutics"},{"key":"1230_CR2","doi-asserted-by":"publisher","first-page":"204.e201","DOI":"10.1016\/j.neurobiolaging.2010.08.006","volume":"33","author":"B Villar-Cheda","year":"2012","unstructured":"Villar-Cheda, B., Valenzuela, R., Rodriguez-Perez, A. I., Guerra, M. J. & Labandeira-Garcia, J. L. Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration. Neurobiol. Aging 33, 204.e201\u2013204.e211 (2012).","journal-title":"Neurobiol. Aging"},{"key":"1230_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/00004872-200205000-00026","volume":"20","author":"P Gohlke","year":"2002","unstructured":"Gohlke, P. et al. Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. J. Hypertens. 20, 909\u2013918 (2002).","journal-title":"J. Hypertens."},{"key":"1230_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1185\/030079903125001974","volume":"19","author":"T Unger","year":"2003","unstructured":"Unger, T. Inhibiting angiotensin receptors in the brain: possible therapeutic implications. Curr. Med. Res. Opin. 19, 449\u2013451 (2003).","journal-title":"Curr. Med. Res. Opin."},{"key":"1230_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41531-024-00650-0","volume":"10","author":"L Lage","year":"2024","unstructured":"Lage, L., Rodriguez-Perez, A. I., Villar-Cheda, B., Labandeira-Garcia, J. L. & Dominguez-Meijide, A. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission. NPJ Parkinsons Dis. 10, 37 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1230_CR6","doi-asserted-by":"publisher","unstructured":"Quijano, A. et al. Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures. Antioxidants 11 https:\/\/doi.org\/10.3390\/antiox11020329 (2022).","DOI":"10.3390\/antiox11020329"},{"key":"1230_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","volume":"31","author":"J Rodriguez-Pallares","year":"2008","unstructured":"Rodriguez-Pallares, J. et al. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol. Dis. 31, 58\u201373 (2008).","journal-title":"Neurobiol. Dis."},{"key":"1230_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath, T. et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat. Neurosci. 25, 588\u2013595 (2022).","journal-title":"Nat. Neurosci."},{"key":"1230_CR9","doi-asserted-by":"publisher","first-page":"eabo2467","DOI":"10.1126\/sciadv.abo2467","volume":"9","author":"AJ Lee","year":"2023","unstructured":"Lee, A. J. et al. Characterization of altered molecular mechanisms in Parkinson\u2019s disease through cell type-resolved multiomics analyses. Sci. Adv. 9, eabo2467 (2023).","journal-title":"Sci. Adv."},{"key":"1230_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-023-00699-0","volume":"19","author":"A Martirosyan","year":"2024","unstructured":"Martirosyan, A. et al. Unravelling cell type-specific responses to Parkinson\u2019s Disease at single cell resolution. Mol. Neurodegener. 19, 7 (2024).","journal-title":"Mol. Neurodegener."},{"key":"1230_CR11","doi-asserted-by":"publisher","first-page":"837890","DOI":"10.3389\/fphar.2022.837890","volume":"13","author":"Y Jo","year":"2022","unstructured":"Jo, Y., Kim, S., Ye, B. S., Lee, E. & Yu, Y. M. Protective effect of renin-angiotensin system inhibitors on Parkinson\u2019s disease: a nationwide cohort study. Front Pharm. 13, 837890 (2022).","journal-title":"Front Pharm."},{"key":"1230_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.amjmed.2022.04.029","volume":"135","author":"HC Lin","year":"2022","unstructured":"Lin, H. C. et al. Association of angiotensin receptor blockers with incident parkinson disease in patients with hypertension: a retrospective cohort study. Am. J. Med. 135, 1001\u20131007 (2022).","journal-title":"Am. J. Med."},{"key":"1230_CR13","doi-asserted-by":"publisher","first-page":"105367","DOI":"10.1016\/j.parkreldis.2023.105367","volume":"110","author":"J Kulisevsky","year":"2023","unstructured":"Kulisevsky, J. et al. A randomized clinical trial of candesartan for cognitive impairment in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 110, 105367 (2023).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1230_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","volume":"14","author":"J Pagonabarraga","year":"2015","unstructured":"Pagonabarraga, J., Kulisevsky, J., Strafella, A. P. & Krack, P. Apathy in Parkinson\u2019s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 14, 518\u2013531 (2015).","journal-title":"Lancet Neurol."},{"key":"1230_CR15","doi-asserted-by":"publisher","unstructured":"Ababei, D. C. et al. Therapeutic implications of renin-angiotensin system modulators in Alzheimer\u2019s dementia. Pharmaceutics 15 https:\/\/doi.org\/10.3390\/pharmaceutics15092290 (2023).","DOI":"10.3390\/pharmaceutics15092290"},{"key":"1230_CR16","doi-asserted-by":"publisher","first-page":"1137197","DOI":"10.3389\/fnagi.2023.1137197","volume":"15","author":"HW Lee","year":"2023","unstructured":"Lee, H. W. et al. Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer\u2019s disease: a nationwide population-based cohort study. Front. Aging Neurosci. 15, 1137197 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1230_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/mdc3.14326","volume":"12","author":"S Bordet","year":"2025","unstructured":"Bordet, S. et al. An open-label, non-randomized, drug-repurposing study to explore the clinical effects of angiotensin II type 1 (AT1) receptor antagonists on anxiety and depression in Parkinson\u2019s disease. Mov. Disord. Clin. Pr. 12, 653\u2013658 (2025).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1230_CR18","doi-asserted-by":"publisher","unstructured":"Gonzalez-Robles, C. et al. Treatment selection and prioritization for the EJS ACT-PD MAMS trial platform. Mov. Disord https:\/\/doi.org\/10.1002\/mds.30190 (2025).","DOI":"10.1002\/mds.30190"},{"key":"1230_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13195-022-01103-7","volume":"14","author":"JT O\u2019Brien","year":"2022","unstructured":"O\u2019Brien, J. T. et al. RENEWAL: repurposing study to find NEW compounds with Activity for Lewy body dementia-an international Delphi consensus. Alzheimers Res. Ther. 14, 169 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"1230_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","volume":"33","author":"DK Jeppesen","year":"2023","unstructured":"Jeppesen, D. K., Zhang, Q., Franklin, J. L. & Coffey, R. J. Extracellular vesicles and nanoparticles: emerging complexities. Trends Cell Biol. 33, 667\u2013681 (2023).","journal-title":"Trends Cell Biol."},{"key":"1230_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40035-022-00330-0","volume":"11","author":"X Xia","year":"2022","unstructured":"Xia, X., Wang, Y. & Zheng, J. C. Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases. Transl. Neurodegener. 11, 53 (2022).","journal-title":"Transl. Neurodegener."},{"key":"1230_CR22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/mds.20914","volume":"21","author":"A Schrag","year":"2006","unstructured":"Schrag, A., Sampaio, C., Counsell, N. & Poewe, W. Minimal clinically important change on the unified Parkinson\u2019s disease rating scale. Mov. Disord. 21, 1200\u20131207 (2006).","journal-title":"Mov. Disord."},{"key":"1230_CR23","doi-asserted-by":"publisher","unstructured":"Heremans, I. P. et al. Parkinson\u2019s disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite. Proc. Natl. Acad. Sci. USA 119 https:\/\/doi.org\/10.1073\/pnas.2111338119 (2022).","DOI":"10.1073\/pnas.2111338119"},{"key":"1230_CR24","doi-asserted-by":"publisher","unstructured":"Skou, L. D., Johansen, S. K., Okarmus, J. & Meyer, M. Pathogenesis of DJ-1\/PARK7-mediated Parkinson\u2019s disease. Cells 13 https:\/\/doi.org\/10.3390\/cells13040296 (2024).","DOI":"10.3390\/cells13040296"},{"key":"1230_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep40859","volume":"7","author":"B Sot","year":"2017","unstructured":"Sot, B. et al. The chaperonin CCT inhibits assembly of alpha-synuclein amyloid fibrils by a specific, conformation-dependent interaction. Sci. Rep. 7, 40859 (2017).","journal-title":"Sci. Rep."},{"key":"1230_CR26","doi-asserted-by":"publisher","unstructured":"Silvestro, S., Raffaele, I. & Mazzon, E. Modulating stress proteins in response to therapeutic interventions for Parkinson\u2019s disease. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms242216233 (2023).","DOI":"10.3390\/ijms242216233"},{"key":"1230_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-021-00272-w","volume":"8","author":"M Yan","year":"2022","unstructured":"Yan, M. et al. Cofilin 1 promotes the pathogenicity and transmission of pathological alpha-synuclein in mouse models of Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 1 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1230_CR28","doi-asserted-by":"publisher","first-page":"101816","DOI":"10.1016\/j.arr.2022.101816","volume":"84","author":"A Kulkarni","year":"2023","unstructured":"Kulkarni, A. et al. Proteostasis in Parkinson\u2019s disease: recent development and possible implications in diagnosis and therapeutics. Ageing Res Rev. 84, 101816 (2023).","journal-title":"Ageing Res Rev."},{"key":"1230_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbr.2011.11.033","volume":"228","author":"J Innos","year":"2012","unstructured":"Innos, J. et al. Deletion of the Lsamp gene lowers sensitivity to stressful environmental manipulations in mice. Behav. Brain Res. 228, 74\u201381 (2012).","journal-title":"Behav. Brain Res."},{"key":"1230_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbadis.2013.10.008","volume":"1842","author":"A Almalki","year":"2014","unstructured":"Almalki, A. et al. Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency. Biochim. Biophys. Acta 1842, 56\u201364 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"1230_CR31","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1073\/pnas.1704351114","volume":"114","author":"R Rott","year":"2017","unstructured":"Rott, R. et al. SUMOylation and ubiquitination reciprocally regulate alpha-synuclein degradation and pathological aggregation. Proc. Natl. Acad. Sci. USA 114, 13176\u201313181 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1230_CR32","first-page":"2442","volume":"7","author":"LP Shu","year":"2015","unstructured":"Shu, L. P., Zhou, Z. W., Zi, D., He, Z. X. & Zhou, S. F. A SILAC-based proteomics elicits the molecular interactome of alisertib (MLN8237) in human erythroleukemia K562 cells. Am. J. Transl. Res 7, 2442\u20132461 (2015).","journal-title":"Am. J. Transl. Res"},{"key":"1230_CR33","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/molecules19022299","volume":"19","author":"F Bellia","year":"2014","unstructured":"Bellia, F., Vecchio, G. & Rizzarelli, E. Carnosinases, their substrates and diseases. Molecules 19, 2299\u20132329 (2014).","journal-title":"Molecules"},{"key":"1230_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00726-021-02975-z","volume":"53","author":"Z Zhou","year":"2021","unstructured":"Zhou, Z. et al. Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients. Amino Acids 53, 687\u2013700 (2021).","journal-title":"Amino Acids"},{"key":"1230_CR35","doi-asserted-by":"publisher","first-page":"e201304004","DOI":"10.5936\/csbj.201304004","volume":"7","author":"S Chandrasekaran","year":"2013","unstructured":"Chandrasekaran, S. & Bonchev, D. A network view on Parkinson\u2019s disease. Comput Struct. Biotechnol. J. 7, e201304004 (2013).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"1230_CR36","doi-asserted-by":"publisher","first-page":"890698","DOI":"10.3389\/fphar.2022.890698","volume":"13","author":"F Li","year":"2022","unstructured":"Li, F., Kang, X., Xin, W. & Li, X. The emerging role of extracellular vesicle derived from neurons\/neurogliocytes in central nervous system diseases: novel insights into ischemic stroke. Front. Pharm. 13, 890698 (2022).","journal-title":"Front. Pharm."},{"key":"1230_CR37","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.4103\/1673-5374.165226","volume":"10","author":"M Okumura","year":"2015","unstructured":"Okumura, M., Miura, M. & Chihara, T. The roles of tubulin-folding cofactors in neuronal morphogenesis and disease. Neural Regen. Res. 10, 1388\u20131389 (2015).","journal-title":"Neural Regen. Res."},{"key":"1230_CR38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1523\/JNEUROSCI.1634-18.2018","volume":"39","author":"S Inoue","year":"2019","unstructured":"Inoue, S. et al. Drebrin-like (Dbnl) controls neuronal migration via regulating N-cadherin expression in the developing cerebral cortex. J. Neurosci. 39, 678\u2013691 (2019).","journal-title":"J. Neurosci."},{"key":"1230_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pneurobio.2018.01.003","volume":"165-167","author":"A Nokkari","year":"2018","unstructured":"Nokkari, A. et al. Implication of the Kallikrein-Kinin system in neurological disorders: quest for potential biomarkers and mechanisms. Prog. Neurobiol. 165-167, 26\u201350 (2018).","journal-title":"Prog. Neurobiol."},{"key":"1230_CR40","doi-asserted-by":"publisher","first-page":"134972","DOI":"10.1016\/j.ijbiomac.2024.134972","volume":"278","author":"R Chen","year":"2024","unstructured":"Chen, R. et al. Chloride intracellular channel 4 blockade improves cognition in mice with Alzheimer\u2019s disease: CLIC4 protein expression and tau protein hyperphosphorylation. Int. J. Biol. Macromol. 278, 134972 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"1230_CR41","doi-asserted-by":"publisher","first-page":"140464","DOI":"10.1016\/j.ijbiomac.2025.140464","volume":"301","author":"S Horvat","year":"2025","unstructured":"Horvat, S. et al. The alpha- to gamma-enolase switch: The role and regulation of gamma-enolase during oligodendrocyte differentiation. Int. J. Biol. Macromol. 301, 140464 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"1230_CR42","doi-asserted-by":"publisher","first-page":"e13235","DOI":"10.1111\/bpa.13235","volume":"34","author":"V Astillero-Lopez","year":"2024","unstructured":"Astillero-Lopez, V. et al. Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer\u2019s disease: potential role in synaptic homeostasis and Abeta pathology through microglial and astroglial cells. Brain Pathol. 34, e13235 (2024).","journal-title":"Brain Pathol."},{"key":"1230_CR43","doi-asserted-by":"publisher","unstructured":"Mitra, S. et al. Natural products targeting Hsp90 for a concurrent strategy in glioblastoma and neurodegeneration. Metabolites 12 https:\/\/doi.org\/10.3390\/metabo12111153 (2022).","DOI":"10.3390\/metabo12111153"},{"key":"1230_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2068","volume":"3","author":"Y Shibata","year":"2012","unstructured":"Shibata, Y. et al. p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO. Nat. Commun. 3, 1061 (2012).","journal-title":"Nat. Commun."},{"key":"1230_CR45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jmcb\/mjv041","volume":"7","author":"L Qu","year":"2015","unstructured":"Qu, L., Ji, Y., Zhu, X. & Zheng, X. hCINAP negatively regulates NF-kappaB signaling by recruiting the phosphatase PP1 to deactivate IKK complex. J. Mol. Cell Biol. 7, 529\u2013542 (2015).","journal-title":"J. Mol. Cell Biol."},{"key":"1230_CR46","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/15548627.2016.1147673","volume":"12","author":"N Jain","year":"2016","unstructured":"Jain, N. & Ganesh, S. Emerging nexus between RAB GTPases, autophagy and neurodegeneration. Autophagy 12, 900\u2013904 (2016).","journal-title":"Autophagy"},{"key":"1230_CR47","doi-asserted-by":"publisher","first-page":"766082","DOI":"10.3389\/fphar.2021.766082","volume":"12","author":"W Cohn","year":"2021","unstructured":"Cohn, W. et al. Multi-omics analysis of microglial extracellular vesicles from human alzheimer\u2019s disease brain tissue reveals disease-associated signatures. Front. Pharm. 12, 766082 (2021).","journal-title":"Front. Pharm."},{"key":"1230_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02613-9","volume":"19","author":"Y Li","year":"2022","unstructured":"Li, Y., Xia, X., Wang, Y. & Zheng, J. C. Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer\u2019s disease. J. Neuroinflam. 19, 248 (2022).","journal-title":"J. Neuroinflam."},{"key":"1230_CR49","doi-asserted-by":"publisher","first-page":"7771","DOI":"10.1523\/JNEUROSCI.1842-04.2004","volume":"24","author":"L Tretter","year":"2004","unstructured":"Tretter, L. & Adam-Vizi, V. Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J. Neurosci. 24, 7771\u20137778 (2004).","journal-title":"J. Neurosci."},{"key":"1230_CR50","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1042\/BCJ20240444","volume":"481","author":"O Yassin","year":"2024","unstructured":"Yassin, O. et al. Opposing regulation of endoplasmic reticulum retention under stress by ERp44 and PDIA6. Biochem. J. 481, 1921\u20131935 (2024).","journal-title":"Biochem. J."},{"key":"1230_CR51","doi-asserted-by":"publisher","first-page":"175628641877425","DOI":"10.1177\/1756286418774254","volume":"11","author":"E Gulke","year":"2018","unstructured":"Gulke, E., Gelderblom, M. & Magnus, T. Danger signals in stroke and their role on microglia activation after ischemia. Ther. Adv. Neurol. Disord. 11, 1756286418774254 (2018).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1230_CR52","doi-asserted-by":"publisher","first-page":"608026","DOI":"10.3389\/fcell.2020.608026","volume":"8","author":"CM Bantle","year":"2020","unstructured":"Bantle, C. M., Hirst, W. D., Weihofen, A. & Shlevkov, E. Mitochondrial dysfunction in astrocytes: a role in Parkinson\u2019s disease?. Front. Cell Dev. Biol. 8, 608026 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1230_CR53","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.it.2024.08.003","volume":"45","author":"G Castelo-Branco","year":"2024","unstructured":"Castelo-Branco, G., Kukanja, P., Guerreiro-Cacais, A. O. & Rubio Rodriguez-Kirby, L. A. Disease-associated oligodendroglia: a putative nexus in neurodegeneration. Trends Immunol. 45, 750\u2013759 (2024).","journal-title":"Trends Immunol."},{"key":"1230_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-024-00410-3","volume":"13","author":"JL Labandeira-Garcia","year":"2024","unstructured":"Labandeira-Garcia, J. L., Labandeira, C. M., Guerra, M. J. & Rodriguez-Perez, A. I. The role of the brain renin-angiotensin system in Parkinson's disease. Transl. Neurodegener. 13, 22 (2024).","journal-title":"Transl. Neurodegener."},{"key":"1230_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-38","volume":"9","author":"P Garrido-Gil","year":"2012","unstructured":"Garrido-Gil, P., Joglar, B., Rodriguez-Perez, A. I., Guerra, M. J. & Labandeira-Garcia, J. L. Involvement of PPAR-gamma in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson\u2019s disease. J. Neuroinflam. 9, 38 (2012).","journal-title":"J. Neuroinflam."},{"key":"1230_CR56","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","volume":"109","author":"B Joglar","year":"2009","unstructured":"Joglar, B. et al. The inflammatory response in the MPTP model of Parkinson\u2019s disease is mediated by brain angiotensin: relevance to progression of the disease. J. Neurochem. 109, 656\u2013669 (2009).","journal-title":"J. Neurochem."},{"key":"1230_CR57","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s11357-011-9284-7","volume":"34","author":"J Rodriguez-Pallares","year":"2012","unstructured":"Rodriguez-Pallares, J., Parga, J. A., Joglar, B., Guerra, M. J. & Labandeira-Garcia, J. L. Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson\u2019s disease. Age 34, 863\u2013880 (2012).","journal-title":"Age"},{"key":"1230_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.327","volume":"7","author":"R Valenzuela","year":"2016","unstructured":"Valenzuela, R. et al. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration. Cell Death Dis. 7, e2427 (2016).","journal-title":"Cell Death Dis."},{"key":"1230_CR59","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.redox.2021.102078","volume":"46","author":"R Valenzuela","year":"2021","unstructured":"Valenzuela, R. et al. An ACE2\/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria. Redox Biol. 46, 102078 (2021).","journal-title":"Redox Biol."},{"key":"1230_CR60","doi-asserted-by":"publisher","unstructured":"Quijano, A. et al. Modulation of mitochondrial dynamics by the angiotensin system in dopaminergic neurons and microglia. Aging Dis. https:\/\/doi.org\/10.14336\/AD.2024.0981 (2024).","DOI":"10.14336\/AD.2024.0981"},{"key":"1230_CR61","doi-asserted-by":"publisher","first-page":"1457459","DOI":"10.3389\/fimmu.2024.1457459","volume":"15","author":"L Lage","year":"2024","unstructured":"Lage, L., Rodriguez-Perez, A. I., Labandeira-Garcia, J. L. & Dominguez-Meijide, A. Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons. Front. Immunol. 15, 1457459 (2024).","journal-title":"Front. Immunol."},{"key":"1230_CR62","doi-asserted-by":"publisher","unstructured":"Lopez-Lopez, A. et al. Interactions between Angiotensin type-1 antagonists, statins, and ROCK inhibitors in a rat model of L-DOPA-induced dyskinesia. Antioxidants 12 https:\/\/doi.org\/10.3390\/antiox12071454 (2023).","DOI":"10.3390\/antiox12071454"},{"key":"1230_CR63","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbi.2017.02.013","volume":"62","author":"A Dominguez-Meijide","year":"2017","unstructured":"Dominguez-Meijide, A., Rodriguez-Perez, A. I., Diaz-Ruiz, C., Guerra, M. J. & Labandeira-Garcia, J. L. Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures. Brain Behav. Immun. 62, 277\u2013290 (2017).","journal-title":"Brain Behav. Immun."},{"key":"1230_CR64","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.neurobiolaging.2014.01.017","volume":"35","author":"B Villar-Cheda","year":"2014","unstructured":"Villar-Cheda, B. et al. Aging-related dysregulation of dopamine and angiotensin receptor interaction. Neurobiol. Aging 35, 1726\u20131738 (2014).","journal-title":"Neurobiol. Aging"},{"key":"1230_CR65","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/j.1460-9568.2010.07448.x","volume":"32","author":"B Villar-Cheda","year":"2010","unstructured":"Villar-Cheda, B. et al. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson\u2019s disease. Eur. J. Neurosci. 32, 1695\u20131706 (2010).","journal-title":"Eur. J. Neurosci."},{"key":"1230_CR66","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/jnc.14821","volume":"150","author":"A Aschrafi","year":"2019","unstructured":"Aschrafi, A. et al. Angiotensin II mediates the axonal trafficking of tyrosine hydroxylase and dopamine beta-hydroxylase mRNAs and enhances norepinephrine synthesis in primary sympathetic neurons. J. Neurochem. 150, 666\u2013677 (2019).","journal-title":"J. Neurochem."},{"key":"1230_CR67","doi-asserted-by":"publisher","first-page":"71514","DOI":"10.18632\/oncotarget.11723","volume":"7","author":"C Backes","year":"2016","unstructured":"Backes, C. et al. Paired proteomics, transcriptomics and miRNomics in non-small cell lung cancers: known and novel signaling cascades. Oncotarget 7, 71514\u201371525 (2016).","journal-title":"Oncotarget"},{"key":"1230_CR68","doi-asserted-by":"publisher","unstructured":"Candamo-Lourido, M. et al. Comparative brain proteomic analysis between sham and cerebral ischemia experimental groups. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms25147538 (2024).","DOI":"10.3390\/ijms25147538"},{"key":"1230_CR69","doi-asserted-by":"publisher","first-page":"106665","DOI":"10.1016\/j.nbd.2024.106665","volume":"201","author":"L Casado-Fernandez","year":"2024","unstructured":"Casado-Fernandez, L. et al. The proteomic signature of circulating extracellular vesicles following intracerebral hemorrhage: novel insights into mechanisms underlying recovery. Neurobiol. Dis. 201, 106665 (2024).","journal-title":"Neurobiol. Dis."},{"key":"1230_CR70","doi-asserted-by":"publisher","first-page":"e0205496","DOI":"10.1371\/journal.pone.0205496","volume":"13","author":"A Abramowicz","year":"2018","unstructured":"Abramowicz, A. et al. Harmonization of exosome isolation from culture supernatants for optimized proteomics analysis. PLoS ONE 13, e0205496 (2018).","journal-title":"PLoS ONE"},{"key":"1230_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47751-1","volume":"15","author":"JS Rodrigues","year":"2024","unstructured":"Rodrigues, J. S. et al. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nat. Commun. 15, 3736 (2024).","journal-title":"Nat. Commun."},{"key":"1230_CR72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2023.06.025","volume":"113","author":"G Torres Iglesias","year":"2023","unstructured":"Torres Iglesias, G. et al. Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in Multiple Sclerosis. Brain Behav. Immun. 113, 44\u201355 (2023).","journal-title":"Brain Behav. Immun."},{"key":"1230_CR73","doi-asserted-by":"publisher","unstructured":"Torres Iglesias, G. et al. Differential protein expression in extracellular vesicles defines treatment responders and non-responders in multiple sclerosis. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms251910761 (2024).","DOI":"10.3390\/ijms251910761"},{"key":"1230_CR74","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1074\/mcp.T600050-MCP200","volume":"6","author":"IV Shilov","year":"2007","unstructured":"Shilov, I. V. et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell Proteom. 6, 1638\u20131655 (2007).","journal-title":"Mol. Cell Proteom."},{"key":"1230_CR75","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01230-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:06:05Z","timestamp":1768403165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01230-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01230-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}